Fosfomycin SynergyIn Vitrowith Amoxicillin, Daptomycin, and Linezolid against Vancomycin-Resistant Enterococcus faecium from Renal Transplant Patients with Infected Urinary Stents

Experience with Fosfomycin for Treatment of Urinary Tract Infections Due to Multidrug-Resistant Organisms

(2012) Elizabeth A. Neuner et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

High-dose daptomycin and fosfomycin treatment of a patient with endocarditis caused by daptomycin-nonsusceptible Staphylococcus aureus: Case report

(2011) Liang-Yu Chen et al.   BMC INFECTIOUS DISEASES

Vancomycin-Resistant Enterococcal Urinary Tract Infections

(2010) Brett H Heintz et al.   PHARMACOTHERAPY

Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections

(2009) Nikos Roussos et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus

(2008) W. E. Rose et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Urinary tract infection in the renal transplant patient

(2008) Ruth M de Souza et al.   Nature clinical practice. Nephrology